We are committed to saving lives by catching cancer early.
We provide novel diagnostic tests to drive the earlier detection of cancer. Using sampling technologies and AI-driven biomarkers we can unlock clinical insights and improve patient outcomes. Through our unique clinical pathway and biomarker data platform, we are positioned to change the patient journey for upper gastrointestinal (GI) disease management.
Bring care forward
We redesign patient journeys to bring health services into primary care closer to patients, reducing burden on specialist providers & hospitals.
Better diagnostics & outcomes
We develop novel diagnostic tools for esophageal cancer & upper GI diseases to fundamentally change how clinicians make decisions and improve patient outcomes.
We demonstrate that with our tools, healthcare systems can reduce costs and unnecessary interventions like endoscopies.